• Font size:
• A
• A
• A

Drug Metabolizing Enzymes (Pharmacogenetic) Testing

Drug Metabolism (Cytochrome P450) Test Request Form
Pharmacogenetic Consult Form
Warfarin Dosing Test Request Form

In August 2007, the Food and Drug Administration changed the Coumadin (Warfarin) label to include specific genetic testing to help identify patients at greater risk for adverse events when starting warfarin therapy. Warfarin sensitivity testing provides rapid turnaround time of results that can assist physicians with dosing decisions. Testing is also available for genetic changes in other enzymes responsible for metabolizing many other commonly prescribed medications used in psychiatry, oncology, pain management, and many other fields of medicine.